A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(See HF 775.)
Impact
If enacted, HSB186 would significantly modify existing laws related to medication abortions by introducing a requirement for physicians to obtain written certification from patients, indicating that they have been informed about the risks and potential options available should they wish to reverse the abortion. This shift aims to centralize the understanding of medication abortion procedures and the alternative possibilities, which may influence women's choices and access to care in the state of Iowa. Additionally, the bill requires the Department of Health and Human Services to create and disseminate informational materials on the reversal of medication abortion effects.
Summary
House Study Bill 186 aims to amend the provisions surrounding medication abortions in Iowa. This legislation focuses on ensuring that women have comprehensive informed consent before undergoing a medication abortion and mandates specific disclosures about the risks and alternatives associated with abortion-inducing drugs such as mifepristone. The bill establishes requirements for healthcare facilities, such as conspicuously posting information about the potential for reversal of medication abortions, which advocates for this bill argue is crucial for patient autonomy and informed decision-making.
Contention
The bill has sparked notable debate among legislators and advocates. Supporters argue that it empowers women by ensuring they have all necessary information about medication abortions, including information about potential reversal procedures. Critics, however, contend that the requirement to inform women of the possibility of reversing a medication abortion may mislead patients about the nature of these procedures and the reality of medication abortion effectiveness. They argue that the additional steps required by HSB186 may create unnecessary barriers to accessing timely healthcare, especially in sensitive situations like unintended pregnancies.
Replaced by
A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(Formerly HSB 186.)
A bill for an act relating to certification requirements for the provision of abortion-inducing drugs, providing penalties, and providing effective date provisions.
A bill for an act prohibiting and requiring certain actions relating to abortion involving the detection of a fetal heartbeat, and including effective date provisions.(See HF 732.)
A bill for an act prohibiting and requiring certain actions relating to abortion involving the detection of a fetal heartbeat, and including effective date provisions. (Formerly HSB 255.) Effective date: 07/14/2023.
A bill for an act prohibiting and requiring certain actions relating to abortion involving the detection of a fetal heartbeat, and including effective date provisions.(See SF 579.)
A bill for an act prohibiting and requiring certain actions relating to abortion involving the detection of a fetal heartbeat, and including effective date provisions.(Formerly SSB 1223.)
A bill for an act relating to the more options for maternal support program, and including effective date and retroactive applicability provisions.(See HF 2267.)
A bill for an act relating to the more options for maternal support program, and including effective date and retroactive applicability provisions.(Formerly HF 2057.)